Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)

Clotilde Guidetti, Stefania Chaikali, Madhukar H. Trivedi, Richard C. Shelton, Dan V. Iosifescu, Michael E. Thase, Manish K. Jha, Sanjay J. Mathew, Charles DeBattista, Mehmet E. Dokucu, Olga Brawman-Mintzer, Jesús Manuel Hernández Ortiz, Glenn W. Currier, William Vaughn McCall, Mandana Modirrousta, Matthew Macaluso, Alexander Bystritsky, Fidel Vila-Rodriguez, Erik B. Nelson, Albert S. YeungLeslie C. MacGregor, Thomas Carmody, Maurizio Fava, George I. Papakostas

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Effect of augmentation with aripiprazole or augmentation with repetitive transcranial magnetic stimulation versus switching to the antidepressant venlafaxine extended release/duloxetine on cognition: A comparative effectiveness research trial for antidepressant incomplete and non-responders with treatment-resistant depression (ASCERTAIN-TRD)'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Keyphrases